David Deitchman

The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement

Michael R. Lassen, Bruce L. Davidson, Alexander Gallus et al. · Journal of Thrombosis and Haemostasis · 2007 · 370 citations

Total Knee Replacement, Thrombosis, Thrombopoiesis +8

Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose‐ranging study

Harry R. Büller, David Deitchman, Martin H. Prins et al. · Journal of Thrombosis and Haemostasis · 2008 · 251 citations · Full text

Thrombosis, Venous Thrombosis, Cardiovascular Disease +6

Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction.

John T. Flaherty, Bertram Pitt, J W Gruber et al. · Circulation · 1994 · 251 citations · Full text

Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol.

Eric J. Eichhorn, John B. Bedotto, Craig R. Malloy et al. · Circulation · 1990 · 243 citations · Full text

Heart Failure, Cardiovascular Disease, Beta-adrenergic Blockade +14

Long-term β-Blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: A double-blind, randomized study of bucindolol versus placebo

E.M. Gilbert, J. G. Anderson, David Deitchman et al. · The American Journal of Medicine · 1990 · 243 citations

Cardiac Function, Cardiomyopathy, Cardiovascular Disease +6